Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: A systematic review of instruments and their measurement properties

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Granger, Catherine L ^a,b   McDonald, Christine F ^b,c   Parry, Selina M ^a,c   Oliveira, Cristino C ^a   Denehy, Linda ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INSTITUTE FOR BREATHING AND SLEEP   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Functional capacity; Measurement properties; NSCLC; Physical activity; Strength; Systematic review

Indexed keywords

12 MINUTE WALK TEST; 6 MINUTE WALK TEST; ACCELEROMETRY; ADULT; AGED; ARTICLE; CANCER STAGING; CHAIR STAND TEST; CLINICAL ASSESSMENT; CLINICAL EVALUATION; ENDURANCE SHUTTLE WALK TEST; FEMALE; FUNCTIONAL STATUS; HAND GRIP DYNAMOMETRY; HAND HELD DYNAMOMETRY; HUMAN; INCREMENTAL SHUTTLE WALK TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MANUAL MUSCLE TEST; MEASUREMENT; MEASUREMENT ERROR; MUSCLE STRENGTH; ONE REPETITION MAXIMUM TEST; OUTCOME ASSESSMENT; PEDOMETRY; PHYSICAL ACTIVITY; RELIABILITY; STAIR CLIMB TEST; SYSTEMATIC REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MOTOR ACTIVITY; MUSCLE STRENGTH; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS;

EID: 84875066739     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-135     Document Type: Article

References (72)

1. Jones L, Eves N, Haykowsky M. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 2009, 10:598-605. 10.1016/S1470-2045(09)70031-2, 19482248.
2. Tanaka K, Akechi T, Okuyama T. Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 2002, 23:417-23. 10.1016/S0885-3924(02)00376-7, 12007759.
3. Granger C, McDonald C, Berney S. Exercise intervention to improve exercise capacity and health related quality of life for patients with Non-small cell lung cancer: a systematic review. Lung Cancer 2011, 72:139-53. 10.1016/j.lungcan.2011.01.006, 21316790.
4. Fleg J, Pina I, Balady G. Assessment of functional capacity in clinical and research applications - an advisory from the committee on exercise, rehabilitation, and prevention, council on clinical cardiology, American heart association. Circulation 2000, 102:1591-1597. 10.1161/01.CIR.102.13.1591, 11004153.
5. Caspersen C. Physical Activity, exercise and physical fitness: definitions and distinctions for health related research. Publ Health Rep 1985, 100:126-131.
6. Bohannon RW. Quantitative testing of muscle strength: issues and practical options for the geriatric population. Top Geriatr Rehabil 2002, 18:1-17.
7. Jones L, Eves N, Mackey J. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Canc 2007, 55:225-32.
8. de Vet H, Terwee C, Mokkink L. Measurement in Medicine - A Practical Guide 2011, Cambridge: Cambridge University Press.
9. Portney L. Foundations of clinical research applications to practice. 2000, Upper Saddle River, NJ: Prentice Hall, Watkins MP, 2.
10. Mokkink L, Terwee C, Knol D. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 2010, 10:22-22. 10.1186/1471-2288-10-22, 2848183, 20298572.
11. Liberati A, Altman D, Tetzlaff J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J 2009, 339:37.
12. NHMRC. National Health Medical Research Council NHMRC additional levels of evidence and grades for recommendations for developers of guidelines 2009, [cited 2012 8 July]; Available from: http://www.nhmrc.gov.au/guidelines/developers.htm, NHMRC. National Health Medical Research Council.
13. National Cancer Institute US National Institutes of Health, Non-Small Cell Lung Cancer Treatment PDQ Summary 2012, 15/10/12]; Available from: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/HealthProfessional/page1, National Cancer Institute.
14. Terwee C, COSMIN group An overview of systematic reviews of measurement properties of measurement instruments that intend to measure (aspects of) health status or (health-related) quality of life 2012, [cited 2012 10.05]; Available from: http://www.cosmin.nl/the-cosmin-checklist_8_5.html, COSMIN group.
15. National Institute for Health Research International Prospective Register of Systematic Reviews (PROSPERO) 2012, [cited 2012 10.05]; Available from: http://www.crd.york.ac.uk/prospero/, National Institute for Health Research.
16. Sim J, Wright C. The kappa statistic in reliability studies: Use, interpretation, and sample size requirements. Phys Ther 2005, 85:257-268.
17. Terwee C, Jansma E, Riphagen I. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res 2009, 18:1115-1123. 10.1007/s11136-009-9528-5, 2744791, 19711195.
18. Terwee C, Mokkink L, Knol D. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 2012, 21:651. 10.1007/s11136-011-9960-1, 3323819, 21732199.
19. Terwee C, Bouwmeester W, van Elsland S. Instruments to assess physical activity in patients with osteoarthritis of the hip or knee: a systematic review of measurement properties. Osteoarthr Cartil 2011, 19:620-33. 10.1016/j.joca.2011.01.002, 21251989.
20. Brunelli A, Xiume F, Refai M. Evaluation of expiratory volume, diffusion capacity, and exercise tolerance following major lung resection: a prospective follow-up analysis. Chest 2007, 131:141-7. 10.1378/chest.06-1345, 17218568.
21. Brunelli A, Al Refai M, Monteverde M. Predictors of exercise oxygen desaturation following major lung resection. Eur J Cardiothorac Surg 2003, 24:145-8. 10.1016/S1010-7940(03)00175-1, 12853059.
22. Pancieri M, Cataneo D, Montovani J. Comparison between actual and predicted postoperative stair-climbing test, walk test and spirometric values in patients undergoing lung resection. Acta Cir Bras 2010, 25:535-540. 10.1590/S0102-86502010000600014, 21120287.
23. Pierce R, Copland J, Sharpe K. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med 1994, 150:947-55. 10.1164/ajrccm.150.4.7921468, 7921468.
24. Saad I, Botega N, Toro I. Predictors of quality-of-life improvement following pulmonary resection due to lung cancer. Sao Paulo Med J 2007, 125:46-49.
25. Kasymjanova G, Correa J, Kreisman H. Prognostic value of the six-minute walk in advanced non-small cell lung cancer. J Thorac Oncol 2009, 4:602-7. 10.1097/JTO.0b013e31819e77e8, 19276833.
26. Mao J, Zhang J, Zhou S. Updated assessment of the six-minute walk test as predictor of acute radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 2007, 67:759-67. 10.1016/j.ijrobp.2006.10.001, 17293233.
27. Miller K, Kocak Z, Kahn D. Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity. IJROBP 2005, 62:1009-1013.
28. Trutschnigg B. Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Met 2008, 33:1232-1239.
29. Koegelenberg C, Diacon A, Irani S. Stair climbing in the functional assessment of lung resection candidates. Respiration 2008, 75:374-379. 10.1159/000116873, 18272936.
30. Win T, Jackson A, Groves A. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax 2006, 61:57-60. 2080711, 16244091.
31. Brunelli A, Xiumé F, Refai M. Peak oxygen consumption measured during the stair-climbing test in lung resection candidates. Respiration 2010, 80:207-211. 10.1159/000279331, 20110651.
32. Brunelli A, Al Refai M, Monteverde M. Stair climbing test predicts cardiopulmonary complications after lung resection. Chest 2002, 121:1106-1109. 10.1378/chest.121.4.1106, 11948039.
33. Brunelli A, Refai M, Xiume F. Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection. Ann Thorac Surg 2008, 86:240-247. discussion 247-248, 10.1016/j.athoracsur.2008.03.025, 18573431.
34. Brunelli A, Refai M, Xiume F. Oxygen desaturation during maximal stair-climbing test and postoperative complications after major lung resections. Eur J Cardiothorac Surg 2008, 33:77-81. 10.1016/j.ejcts.2007.09.028, 17983763.
35. Brunelli A, Monteverde M, Al Refai M. Stair climbing test as a predictor of cardiopulmonary complications after pulmonary lobectomy in the elderly. Ann Thorac Surg 2004, 77:266-270. 10.1016/S0003-4975(03)01327-4, 14726076.
36. Nikolic I, Majeric-Kogler V, Plavec D. Stairs climbing test with pulse oximetry as predictor of early postoperative complications in functionally impaired patients with lung cancer and elective lung surgery: prospective trial of consecutive series of patients. Croat Med J 2008, 49:50-7. 10.3325/cmj.2008.1.50, 2269232, 18293457.
37. Toker A, Ziyade S, Bayrak Y. Prediction of cardiopulmonary morbidity after resection for lung cancer: Stair climbing test complications after lung cancer surgery. Thorac Cardiovasc Surg 2007, 55:253-256. 10.1055/s-2006-955941, 17546557.
38. Pate P, Tenholder M, Griffin J. Preoperative assessment of the high-risk patient for lung resection. Ann Thorac Surg 1996, 61:1494-500. 10.1016/0003-4975(96)00087-2, 8633965.
39. Parsons J, Johnston M, Slutsky A. Predicting length of stay out of hospital following lung resection using preoperative health status measures. Qual Life Res 2003, 12:645-54. 10.1023/A:1025147906867, 14516174.
40. Jones L, Hornsby W, Goetzinger A. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer 2012, 76:248-252. 10.1016/j.lungcan.2011.10.009, 3615546, 22112290.
41. Holden D, Rice T, Stelmach K. Exercise testing, 6-min walk and stair climb in the evaluation of patients at high-risk for pulmonary resection. Chest 1992, 102:1774-1779. 10.1378/chest.102.6.1774, 1446488.
42. Brunelli A, Sabbatini A, Xiume F. Inability to perform maximal stair climbing test before lung resection: a propensity score analysis on early outcome. Eur J Cardiothorac Surg 2005, 27:367-72. 10.1016/j.ejcts.2004.11.012, 15740940.
43. Brunelli A, Pompili C, Berardi R. Performance at Preoperative Stair-Climbing Test Is Associated With Prognosis After Pulmonary Resection in Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg 2012, 93(6):1796-1801. 10.1016/j.athoracsur.2012.02.068, 22551844.
44. England R, Maddocks M, Manderson C. Factors influencing exercise performance in thoracic cancer. Respir Med 2012, 106(2):294-299. 10.1016/j.rmed.2011.11.002, 22104542.
45. Vanhees L, Lefevre J, Philippaerts R. How to assess physical activity? How to assess physical fitness?. Eur J Cardiovasc Prev Rehabil 2005, 12:102-114.
46. Maddocks M. Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study. Support Care Canc 2010, 18:1539-1544.
47. Maddocks M, Wilcock A. Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure. Support Care Canc 2012, 20:1113-6.
48. Du-Quiton J, Wood P, Burch J. Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psychooncology 2010, 19:180-189. 10.1002/pon.1539, 19199317.
49. Grutsch J, Ferrans C, Wood P. The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Canc 2011, 11:193.
50. Grutsch J, Wood P, Du-Quiton J. Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer. J Circadian Rhy 2011, 9:4-4.
51. Novoa N, Varela G, Jimenez M. Value of the average basal daily walked distance measured using a pedometer to predict maximum oxygen consumption per minute in patients undergoing lung resection. Eur J Cardiothorac Surg 2011, 39:756-62. 10.1016/j.ejcts.2010.08.025, 21146419.
52. Knols R, Stappaerts K, Fransen J. Isometric strength measurement for muscle weakness in cancer patients: reproducibility of isometric muscle strength measurements with a hand-held pull-gauge dynamometer in cancer patients. Support Care Canc 2002, 10:430-8.
53. Brown D, McMillan D, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 2005, 103:377-82. 10.1002/cncr.20777, 15558809.
54. Maddocks M, Mockett S, Wilcock A. Is exercise an acceptable and practical therapy for people with or cured of cancer? A systematic review. Canc Treat Rev 2009, 35:383-390.
55. Jones L, Eves N, Haykowsky M. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol 2008, 9:757-765. 10.1016/S1470-2045(08)70195-5, 18672211.
56. American Thoracic Society ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117. American Thoracic Society.
57. Alison JA, Kenny P, King MT. Repeatability of the Six-Minute Walk Test and Relation to Physical Function in Survivors of a Critical Illness. Phys Ther 2012, 91(12):1556.
58. Solway S, Brooks D, Lacasse Y. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001, 119:256-270. 10.1378/chest.119.1.256, 11157613.
59. Jenkins SC. 6-Minute walk test in patients with COPD: clinical applications in pulmonary rehabilitation. Physiotherapy 2007, 93:175-182.
60. Bellet N, Adams L, Morris N. Systematic review: The 6-minute walk test in outpatient cardiac rehabilitation: validity, reliability and responsiveness-a systematic review. Physiotherapy 2012, 98(4):277-287. 10.1016/j.physio.2011.11.003, 23122432.
61. Sadaria K, Bahannon R. The 6-minute walk test: a brief review of literature. Clin Exerc Physiol 2001, 3:127.
62. Andersen A, Vinther A, Poulsen L. Do patients with lung cancer benefit from physical exercise?. Acta Oncol 2011, 50:307-13. 10.3109/0284186X.2010.529461, 21231792.
63. Maddocks M, Lewis M, Chauhan A. Randomized controlled pilot study of neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer. J Pain Symptom Manage 2009, 38:950-6. 10.1016/j.jpainsymman.2009.05.011, 19748761.
64. Win T, Jackson A, Groves A. Relationship of shuttle walk test and lung cancer surgical outcome. Eur J Cardiothorac Surg 2004, 26:1216-9. 10.1016/j.ejcts.2004.07.036, 15541987.
65. Singh S, Morgan M, Scott S. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992, 47:1019-24. 10.1136/thx.47.12.1019, 1021093, 1494764.
66. Leenders N, Sherman W, Nagaraja H. Energy expenditure estimated by accelerometry and doubly labeled water: do they agree?. Med Sci Sports Exerc 2006, 38:2165-2172. 10.1249/01.mss.0000235883.94357.95, 17146325.
67. Bluck L. Doubly labelled water for the measurement of total energy expenditure in man - progress and applications in the last decade. Br Nutr Foundation Nutr Bull 2008, 33:80-90.
68. Innes E. Handgrip strength testing: a review of the literature. Aust Occup Ther J 1999, 46:120-140.
69. Bohannon RW. Responsiveness of hand-held dynamometry to changes in limb muscle strength: a retrospective investigation of published research. Isokinet Exer Sci 2009, 17:221-5.
70. Martin H. Is hand-held dynamometry useful for the measurement of quadriceps strength in older people? A comparison with the gold standard biodex dynamometry. Gerontology 2006, 52:154-159. 10.1159/000091824, 16645295.
71. Ciesla N, Dinglas V, Fan E. Manual muscle testing: a method of measuring extremity muscle strength applied to critically ill patients. J Vis Exp 2011, 12(50):e2632.
72. Hough C, Lieu B, Caldwell E. Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care 2011, 15:R43. 10.1186/cc10005, 3221972, 21276225.